Home > Back to Publisher > Report Information

Impact of Patent Expiry on Global Generic Drugs Market - Trends, Opportunities and Challenges Post 2011

Synergyst
January 1, 2012
80 Pages - SKU: SYGR6745823

Abstract Table of Contents Search inside this report Related Reports

Countries covered: Global

Fueled by ageing populations, growing numbers of patent expirations and government cost-cutting measures, the global generic drugs market continues to grow. In 2010, sales of generic drugs worldwide is estimated at almost US$170 billion; a CAGR of 9.7% in last five years. It is well known that key patents of multi-billion dollar brand drugs are set to expire within the next few years. The loss of over 200,000 pharmaceutical jobs over the past three years has been mainly driven by the anticipated loss of revenue from blockbuster drugs that will lose patent protection by 2013. Consistent with trends of the past several years, the next five years are expected to reflect a significant imbalance between new product introductions and patent losses. This is the primary factor limiting global pharmaceutical market growth to the mid-single digits through 2013. The on-going patent expirations will force generic manufacturers to replenish product pipelines with new generic versions to expand markets such as the United States, the world's largest generic drug market, and one of the very few countries worldwide where generics fill more than 50% of prescriptions.

Over the next five years, products that currently generate an unprecedented $137 billion in sales are expected to face generic competition. At the same time, new products that will enable innovative approaches for treating patients suffering from diseases such as osteoporosis, respiratory ailments, thrombosis, multiple sclerosis and cancer are not expected to generate the same magnitude of sales as products losing patent protection. Many large multinational companies are beginning to explore the untapped potential of emerging economies, particularly Brazil, Russia, India and China, which are growing at robust double-digit rates because of the economic boom, massive population growth and large number of health care reforms being introduced by the governments. Over the next few years, markets will be impacted by numerous payer actions, including the imposition of price cuts on existing drugs, the raising of standards required to achieve reimbursement of innovative therapies, and the use of economic incentives for prescribers and pharmacists to drive a shift to generic alternatives.

Synergyst's "Impact of Patent Expiry on Global Generic Drugs Market - Trends, Opportunities and Challenges Post 2011" focuses on the current generics market globally and the impact of patent expirations will have on the market in future.

Report Coverage and Highlights

Detailed analysis of the global pharmaceutical industry with historic sales trends and forecast for future growth of the overall market.
Global generics market is discussed in detail focusing on current market sizing, geographic segmentation, growth and penetration trends, and outlook for generics market.
Key generic drugs markets - United States, Europe and Japan - are discussed with analysis of current and future market sizing and key regulations that govern the generic drugs in each of these markets.
Report discusses in detail all the trends that are affecting the global generics market and challenges that industry is facing.
A comprehensive analysis of on-going patent expirations and its impact on generics market is presented along with the strategies that various generic and non-generic pharma companies are adopting to stay profitable.
Report provides information on the opportunities that will be presented as a result of patent expiration in all the major markets.
Finally, a detailed analysis of the competition in generics market is presented with detailed profiles of leading generic drug manufacturers.

I. EXECUTIVE SUMMARY
II. GLOBAL PHARMACEUTICAL INDUSTRY: a. Global Pharmaceutical Industry Revenues; b. Market Forecast (2011-2015)
III. GLOBAL GENERIC DRUG MARKET: a. Introduction to Generic Drugs; b. Current Market Sizing; c. Geographic Segmentation of Generics Market; d. Growth in Generics; e. Degree of Generic Penetration; f. Top Generic Markets; g. Generic Erosion of Expired Brands; h. Forecast for Generics Market
IV. KEY GENERIC DRUGS MARKETS AND REGULATIONS: a. United States; b. Japan; c. Europe
V. TRENDS AND CHALLENGES IN GENERICS MARKETS: a. Industry Trends; b. Challenges Facing Industry
VI. PATENT EXPIRATION AND PATENT CLIFF
VII. STRATEGIES OF GENERIC DRUGS MANUFACTURERS: a. Market Entry Strategies; b. Increase in M&A Activity; c. Vertical Integration by Players; d. Therapeutic Expansions; e. Companies Opting for Authorized Generics; f. Companies Utilizing Outsourcing to Maximize Profits; g. Importance of Brazil, Russia, India, and China
VIII. MAJOR PIPELINE OPPORTUNITIES FOR GENERIC DRUGS COMPANIES
IX. COMPETITION AND COMPANY PROFILES OF MAJOR PLAYERS: a. Competitive Landscape; b. Company Profiles
X. GLOSSARY
LIST OF FIGURES: Figure 1: Global Pharmaceutical Industry Revenues and Growth (2000-2010); Figure 2: Global Pharmaceutical Industry Revenues by Region (2010); Figure 3: Forecast for Global Pharmaceutical Industry (2010-2015); Figure 4: Global Generics Industry Revenues and Growth (2006-2010); Figure 5: Global Generics Volume Sales as a Percentage of Global Pharma Sales (2006-2010); Figure 6: Geographic Segmentation of the Global Generics Market (2010); Figure 7: Impact of Patent Expiry on Global Branded Pharmaceutical Sales (2010-2014); Figure 8: Impact of Patent Expiry on Future Sales of Top Pharma Companies (2010-2015); Figure 9: Forecast for Global Generics Industry Revenues and Growth (2010-2015); Figure 10: United States - Share of Generic Pharmaceutical as Prescription Sales (2005-2010); Figure 11: Comparison of Japanese and Other Major Regulatory Agencies (1998-2008; Figure 12: Per Capita Spending on Pharmaceuticals and Life Expectancy in Europe (2005-2010); Figure 13: Country-wise Share of European Generics Market (2010); Figure 14: Price Erosion Curves of Generic Products at Patent Expiry in U.S. and EU; Figure 15: Top Pharmaceutical Companies by Number of Products Loosing Patent; Figure 16: Top 10 Drugs By 2010 Global Revenues Going Off-Patent Between 2010-2014; Figure 17: Market Opportunities as Result of Patent Expiration in United States (2010-2016); Figure 18: Increase in Generic Drugs Utilization in United States (2004-2016); Figure 19: Global Market Opportunities for Generic Drugs (2010-2016); Figure 20: Top 5 Generic Companies by 2010 Revenues
LIST OF TABLES: Table 1: Top 20 Pharmaceutical Products Worldwide By Sales (2010); Table 2: Key Blockbuster Pharmaceuticals Loosing Patent in Japan (2010-2012); Table 3: Europe - Generic and Non-Generic Pharma Sales by Volume and Value (2005-2009); Table 4: Patent Expiration and Revenue Loss to Companies (2011-2013); Table 5: Significant Backward Integration by Generic Players; Table 6: Listing of Major Drugs Going Off-Patent in United States (2011-2014); Table 7: Listing of Major Brands going Off-Patent in Europe (2011-2013); Table 8: Listing of Major Brands going Off-Patent in Japan (2011-2014)

More Global Manufacturing, Packaging & Detailing Reports

Outsourcing in Drug Discovery: The Contract Research Organization (CRO) Market, 5th Edition by Kalorama Information
The drug discovery process is long, arduous and costly, which has driven outsourcing in this field. The first phase is discovery of a lead compound, ...

The World Market for Over The Counter (OTC) Drugs by Kalorama Information
Over-the-counter (OTC), non-legend, and non-prescription are all adjectives describing drugs that an individual may purchase without a prescription. Many pharmaceutical companies seeking more revenue and ...

Global Pharmaceuticals & Medicine Manufacturing by IBISWorld
Global Pharmaceuticals & Medicine Manufacturing This industry comprises companies that manufacture biological, medicinal and pharmaceutical products in various forms including ampoules, tablets, capsules, vials, ointments, powders, ...

Global Pharmaceutical Survey 2012–2013: Market Trends, Marketing Spend and Sales Strategies in the Global Pharmaceutical Industry by iCD Research
Synopsis This report is the result of an extensive survey drawn from ICD Research’s exclusive panel of leading pharmaceutical industry executives. The opinions and ...

Global Pharmaceutical Survey 2012–2013: Market Trends, Buyer Spend and Procurement Strategies in the Global Pharmaceutical Industry by iCD Research
Synopsis This report is the result of an extensive survey drawn from ICD Research’s exclusive panel of leading pharmaceutical industry executives. The opinions and ...

See all reports like this >>

Impact of Patent Expiry on Global Generic Drugs Market - Trends, Opportunities and Challenges Post 2011

Share this report

Other tasks

Research Assistance

Related Markets

Manufacturing, Packaging & Detailing Reports

Free Alert Me service